1] ARUP Laboratories, Salt Lake City, Utah, USA [2] Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
Genet Med. 2013 Nov;15(11):901-9. doi: 10.1038/gim.2013.129. Epub 2013 Sep 26.
Microarray methodologies, including array comparative genomic hybridization and single-nucleotide polymorphism-detecting arrays, are accepted as an appropriate first-tier test for the evaluation of imbalances associated with intellectual disability, autism, and multiple congenital anomalies. This technology also has applicability in prenatal specimens. To assist clinical laboratories in validation of microarray methodologies for constitutional applications, the American College of Medical Genetics and Genomics has produced the following revised professional standards and guidelines.
微阵列方法学,包括 array comparative genomic hybridization 和 single-nucleotide polymorphism-detecting arrays,被接受为评估与智力障碍、自闭症和多种先天性异常相关的不平衡的适当的一级测试。这项技术在产前标本中也有应用。为了帮助临床实验室验证用于遗传性应用的微阵列方法学,美国医学遗传学与基因组学学院制定了以下修订后的专业标准和指南。